Pharmacotherapy of obesity: an update on the available medications and drugs under investigation

M Chakhtoura, R Haber, M Ghezzawi, C Rhayem… - …, 2023 - thelancet.com
Obesity is an epidemic and a public health threat. Medical weight management remains one
of the options for the treatment of excess weight and recent advances have revolutionized …

Brown adipose tissue—a translational perspective

AC Carpentier, DP Blondin, F Haman… - Endocrine …, 2023 - academic.oup.com
Brown adipose tissue (BAT) displays the unique capacity to generate heat through
uncoupled oxidative phosphorylation that makes it a very attractive therapeutic target for …

Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network

H Mosbah, MC Vantyghem, E Nobécourt… - Diabetes, Obesity …, 2022 - Wiley Online Library
Aim To describe baseline characteristics and follow‐up data in patients with lipodystrophy
syndromes treated with metreleptin in a national reference network, in a real‐life setting …

Therapeutic advances in obesity management: an overview of the therapeutic interventions

MA Roomy, K Hussain, HM Behbehani… - Frontiers in …, 2024 - frontiersin.org
Obesity has become a global epidemic in the modern world, significantly impacting the
global healthcare economy. Lifestyle interventions remain the primary approach to …

Leptin decreases gluconeogenesis and gluconeogenic substrate availability in patients with lipodystrophy

E Quaye, S Chacko, M Startzell… - The Journal of Clinical …, 2024 - academic.oup.com
Context The effects of leptin, an adipocyte-derived hormone that signals overall energy
sufficiency, can only be studied in leptin-deficient conditions. In patients with lipodystrophy, a …

Long-term effects of metreleptin in Rabson-Mendenhall syndrome on glycemia, growth, and kidney function

MC Okawa, E Cochran, M Lightbourne… - The Journal of Clinical …, 2022 - academic.oup.com
Abstract Context Rabson-Mendenhall syndrome (RMS) is caused by biallelic pathogenic
variants in the insulin receptor gene (INSR) leading to insulin-resistant diabetes …

Energy expenditure due to gluconeogenesis in pathological conditions of insulin resistance

E Quaye, S Chacko, ST Chung… - American Journal …, 2021 - journals.physiology.org
Gluconeogenesis (GNG), the formation of glucose from noncarbohydrate precursors,
requires adenosine triphosphate (ATP). Previous studies have estimated the energetic cost …

[HTML][HTML] Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy

M Nicze, A Dec, M Borówka, D Krzyżak… - … Journal of Molecular …, 2024 - ncbi.nlm.nih.gov
Obesity is a chronic disease caused primarily by the imbalance between the amount of
calories supplied to the body and energy expenditure. Not only does it deteriorate the quality …

Advancements in the management of obesity: a review of current evidence and emerging therapies

MA Abdalla Ahmed, E Ssemmondo… - Expert Review of …, 2024 - Taylor & Francis
Introduction Obesity is the modern world's current epidemic, with substantial health and
economic impact. This study aimed to provide a narrative overview of the past, currently …

Leptin improves parameters of brown adipose tissue thermogenesis in lipodystrophic mice

A Hoffmann, T Ebert, MK Hankir, G Flehmig, N Klöting… - Nutrients, 2021 - mdpi.com
Lipodystrophy syndromes (LD) are a heterogeneous group of very rare congenital or
acquired disorders characterized by a generalized or partial lack of adipose tissue. They are …